The iRR6 model refines risk stratification for intermediate-1 myelofibrosis patients, incorporating ruxolitinib dosing, spleen reduction, and transfusion needs. Validation in an external cohort ...
Cell state transitions are phenotypic changes in the state of a cell, primarily driven by transcriptional programs. Such phenotypic transitions underlie development, regeneration, and cancer. Our ...
NCCN 2026 Bladder Cancer Guidelines Adopt IBCG Risk Stratification Model for Intermediate-Risk NMIBC
The 2026 NCCN Bladder Cancer Guidelines incorporate the IBCG five-factor model, introducing standardized risk stratification for intermediate-risk NMIBC. For decades, heterogeneity in ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results